Whitman, S. P., Archer, K. J., Feng, L., Baldus, C., Becknell, B., Carlson, B. D., … Caligiuri, M. A. (2001). The FLT3 internal tandem duplication in normal karyotype adult de novo AML lacking the wildtype FLT3 gene predicts poor prognosis: A Cancer and Leukemia Group B study. CLINICAL CANCER RESEARCH, 7(11), 3767S-3767S.

Whitman, S. P., K. J. Archer, L. Feng, C. Baldus, B. Becknell, B. D. Carlson, A. J. Carroll, et al. “The FLT3 internal tandem duplication in normal karyotype adult de novo AML lacking the wildtype FLT3 gene predicts poor prognosis: A Cancer and Leukemia Group B study.” CLINICAL CANCER RESEARCH 7, no. 11 (November 1, 2001): 3767S-3767S.

Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, et al. The FLT3 internal tandem duplication in normal karyotype adult de novo AML lacking the wildtype FLT3 gene predicts poor prognosis: A Cancer and Leukemia Group B study. CLINICAL CANCER RESEARCH. 2001 Nov 1;7(11):3767S-3767S.

Whitman, S. P., et al. “The FLT3 internal tandem duplication in normal karyotype adult de novo AML lacking the wildtype FLT3 gene predicts poor prognosis: A Cancer and Leukemia Group B study.” CLINICAL CANCER RESEARCH, vol. 7, no. 11, AMER ASSOC CANCER RESEARCH, Nov. 2001, pp. 3767S-3767S.

Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, Carroll AJ, Mrozek K, Vardiman JW, George SL, Kolitz JE, Larson RA, Bloomfield CD, Caligiuri MA. The FLT3 internal tandem duplication in normal karyotype adult de novo AML lacking the wildtype FLT3 gene predicts poor prognosis: A Cancer and Leukemia Group B study. CLINICAL CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2001 Nov 1;7(11):3767S-3767S.